Literature DB >> 25560159

Immunoglobulin levels and CD4 / CD8 counts in β- thalassemia major.

P P Kadam1, M V Manglani, S M Sharma, R A Sharma, M S Setia.   

Abstract

OBJECTIVE: This cross-sectional study determined the CD4, CD8 counts and serum immunoglobulins in transfusion dependent b - thalassemic patients, and correlated them with anti-HIV, anti-HCV and HBsAg status, number of transfusions, iron overload and splenectomy.
METHODS: Patients with acute or chronic diseases (except HIV, Hepatitis B and C), on immunosuppressive drugs or vaccinated within one month prior to study were excluded. CD4, CD8 counts and serum Immunoglobulins were documented.
RESULTS: Increasing transfusions led to higher IgA and IgM as well as a decline in CD4 and CD8 levels. Higher ferritin correlated with high IgM. CD4, CD8 and IgA were significantly higher in splenectomized subjects. HCV correlated significantly with lower IgA values.
CONCLUSION: Higher transfusion requirement, iron overload, splenectomy and HCV infection correlated with alterations in different immunological parameters.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25560159     DOI: 10.1007/s13312-014-0546-1

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  3 in total

1.  Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major.

Authors:  Asmaa M Zahran; Khaled Saad; Khalid I Elsayh; Mohamd A Alblihed
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

2.  Therapeutic effects of laparotomy and laparoscopic surgery on patients with gastric cancer.

Authors:  Yang Hu; Gaoping Zhao; Heng Zheng
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

3.  Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia.

Authors:  Tubagus Djumhana Atmakusuma; Ralph Girson; Sukamto Koesnoe
Journal:  Anemia       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.